retatrutide trials weight loss (“reta”) is an experimental weight-loss drug currently in Phase 3 clinical trials. It's a once-weekly injection similar to Ozempic and Mounjaro—but more powerful. The reason comes down to how it works Retatrutide Promises Big Weight Loss,

Fighting a digital hydra The Pharmaceutical Task Group , an industry body representing organised pharmacy and manufacturing interests, views this underground trade as a direct violation of the laws protecting the South African public

Subcutaneous weekly semaglutide with automated insulin delivery in type 1 diabetes: a double-blind, randomized, crossover trial

Nausea is the single most common side effect of GLP-1 receptor agonist medications and the most common reason patients in clinical trials and in clinic discontinue treatment

doi:10.1038/s41591-024-03018-2

Moreover, periodic body composition assessment (e.g., through DXA or BIA) is advisable in order to early detect disproportionate loss of lean mass and to adapt nutritional interventions accordingly [42]